DK0552280T3 - Inhibering af viral replikation - Google Patents

Inhibering af viral replikation

Info

Publication number
DK0552280T3
DK0552280T3 DK91919581.8T DK91919581T DK0552280T3 DK 0552280 T3 DK0552280 T3 DK 0552280T3 DK 91919581 T DK91919581 T DK 91919581T DK 0552280 T3 DK0552280 T3 DK 0552280T3
Authority
DK
Denmark
Prior art keywords
inhibition
viral replication
dna
cell
viral
Prior art date
Application number
DK91919581.8T
Other languages
Danish (da)
English (en)
Inventor
Michael J Scolaro
Sean M Sullivan
Original Assignee
Nexstar Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nexstar Pharmaceuticals Inc filed Critical Nexstar Pharmaceuticals Inc
Application granted granted Critical
Publication of DK0552280T3 publication Critical patent/DK0552280T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1131—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
    • C12N15/1132—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses against retroviridae, e.g. HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • AIDS & HIV (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK91919581.8T 1990-10-09 1991-10-09 Inhibering af viral replikation DK0552280T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US59525390A 1990-10-09 1990-10-09

Publications (1)

Publication Number Publication Date
DK0552280T3 true DK0552280T3 (da) 1995-08-28

Family

ID=24382446

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91919581.8T DK0552280T3 (da) 1990-10-09 1991-10-09 Inhibering af viral replikation

Country Status (9)

Country Link
EP (1) EP0552280B1 (de)
JP (1) JPH06504429A (de)
AT (1) ATE124457T1 (de)
AU (1) AU652006B2 (de)
CA (1) CA2093816A1 (de)
DE (1) DE69110897T2 (de)
DK (1) DK0552280T3 (de)
ES (1) ES2073777T3 (de)
WO (1) WO1992006192A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3351476B2 (ja) * 1993-01-22 2002-11-25 三菱化学株式会社 リン脂質誘導体及びそれを含有するリポソーム
EP0734251B1 (de) * 1993-12-17 2009-10-14 Novavax, Inc. Verfahren zur übertragung eines biologisch aktiven materials an eine zelle
JP4259611B2 (ja) * 1994-08-29 2009-04-30 ウェイク フォレスト ユニバーシティ ウィルス感染を治療するための脂質アナログ
US7135584B2 (en) 1995-08-07 2006-11-14 Wake Forest University Lipid analogs for treating viral infections
US6776986B1 (en) 1996-06-06 2004-08-17 Novartis Ag Inhibition of HIV-1 replication by antisense RNA expression
US7026469B2 (en) 2000-10-19 2006-04-11 Wake Forest University School Of Medicine Compositions and methods of double-targeting virus infections and cancer cells
US7309696B2 (en) 2000-10-19 2007-12-18 Wake Forest University Compositions and methods for targeting cancer cells
IL160080A0 (en) 2001-08-31 2004-06-20 Thomson Licensing Sa Sequence counter for an audio visual stream
WO2005027979A2 (en) * 2003-09-17 2005-03-31 Let There Be Hope Medical Research Institute Targeted lipid-drug formulations for delivery of drugs to myeloid and lymphoid immune cells

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3853139T2 (de) * 1987-06-26 1995-06-14 Syntro Corp Rekombinanter, fremde gene enthaltender menschlicher cytomegalovirus und seine verwendung.
DE3742049A1 (de) * 1987-12-11 1989-06-22 Theurer Karl Eugen Herstellung und anwendung von impfstoffen und diagnostika fuer virus- und krebserkrankungen
AU636573B2 (en) * 1988-02-26 1993-05-06 Worcester Foundation For Biomedical Research, Inc. Inhibition of htlv-iii by exogenous oligonucleotides

Also Published As

Publication number Publication date
JPH06504429A (ja) 1994-05-26
ES2073777T3 (es) 1995-08-16
EP0552280B1 (de) 1995-06-28
CA2093816A1 (en) 1992-04-10
DE69110897D1 (de) 1995-08-03
EP0552280A1 (de) 1993-07-28
AU8875991A (en) 1992-04-28
WO1992006192A1 (en) 1992-04-16
ATE124457T1 (de) 1995-07-15
AU652006B2 (en) 1994-08-11
DE69110897T2 (de) 1995-11-30

Similar Documents

Publication Publication Date Title
DK0702085T4 (da) Rekombinant infektiøs ikke-segmenteret negativ-strenget RNA-virus
DE69535125D1 (de) Impstoff gegen felines immunodefizienz-virus
ES2140418T3 (es) Flavivirus quimericos y/o flavivirus de crecimiento restringido.
DE69122248D1 (de) Hemmung einer virusinfektion
DK0552280T3 (da) Inhibering af viral replikation
DE60126933D1 (de) Verfahren zur fermentativen herstellung von l-threonine
DE69429249T2 (de) Gegen plrv-infektion resistente pflanzen
NO893090L (no) Kurskorreksjonssystem for objekter, hvis kurs kan korrigeres.
DK0599868T3 (da) Polyphenoloxidase-gener
DE60233875D1 (de) Attenuierter circovirus
AU2001279581A1 (en) Medicament comprising a dna sequence, which codes for the rna-binding koc protein, and comprising a koc protein or dna sequence of the koc promoter
ES2062990T3 (es) Vacunas, que contienen la proteina f del virus del sida.
ATE442441T1 (de) Virale expressionsvektoren für pflanzen
DE69534945D1 (de) Impfstoff für die infektiöse peritonitis der katzen
ES2367245T8 (es) Virus recombinante que expresa adn foráneo que codifica cd80 felino, cd28 felino, ctla-4felino o cd86 felino y usos del mismo.
DE69733948D1 (de) In vivo herstellung von replicativen molekülen
DE50304603D1 (de) Impfstoff gegen infektionen mit onkoviren, wie dem felinen leukosevirus der katze
WO1998042847A3 (de) Papillomvirus-hauptcapsid-proteins und deren verwendung in diagnose, therapie und vakzinierung
WO2000042063A3 (de) Peptide zur inhibierung von hbv-core-proteinen
WO2004027066A3 (fr) Protéine recombinante chimérique et diagnostic in vitro du hiv
FI890231A (fi) Çkaerlekssigillç, aer ett çlaosç som laoses antingen med verktyg eller foer hand, men som inte kan upplaoses utan att den gaor soender.
FI893346A0 (fi) Icke-reverterande rna-virus.
FI902814A0 (fi) Proteiner, vaccin och nukleinsyror.
IT248974Y1 (it) Supporto per placchette di nasello per occhiali,particolarmente deltipo in pietra.